Esperion Therapeutics (NASDAQ: ESPR) shares reached a new 52-week high of $27.905 after the company announced positive top-line Phase 2b results for ETC-1002.
Sagent Pharmaceuticals (NASDAQ: SGNT) shares touched a new 52-week high of $32.12...
Reis, Inc. (NASDAQ:REIS)
Q2 2014 Earnings Conference Call
July 31, 2014 11:00 AM ET
Lloyd Lynford – Chief Executive Officer
Mark Cantaluppi – Vice President and Chief Financial Officer
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.